T2 Biosystems, Inc.

CIK 1492674 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for T2 Biosystems, Inc..

Recent SEC filings

FiledFormAccession number
Jul 10, 202525-NSE/A0001354457-25-000637
Jul 10, 202525-NSE0001354457-25-000634
Apr 7, 20258-K0001193125-25-073558
Apr 1, 2025NT 10-K0001193125-25-069923
Feb 20, 20258-K0001193125-25-030194
Feb 14, 20258-K0001193125-25-027311
Feb 13, 2025SCHEDULE 13G/A0000921895-25-000416
Feb 13, 2025SCHEDULE 13G/A0000921895-25-000417
Feb 11, 20258-K0001193125-25-024057
Jan 21, 2025DEF 14A0001193125-25-009553
Jan 17, 20258-K0001193125-25-008125
Jan 8, 2025PRE 14A0001193125-25-003559
Jan 7, 20258-K0001193125-25-002629
Jan 3, 20258-K0001193125-25-001537
Jan 2, 202540000950170-25-000603
Jan 2, 202540000950170-25-000583
Jan 2, 202540000950170-25-000596
Jan 2, 202540000950170-25-000592
Jan 2, 202540000950170-25-000589
Jan 2, 202540000950170-25-000586
Jan 2, 202540000950170-25-000606
Jan 2, 202540000950170-25-000584
Jan 2, 202540000950170-25-000610
Jan 2, 202540000950170-25-000579
Dec 13, 20248-K0001193125-24-277962